Reduced systemic inflammation may lower the inflammatory tone in the brain
As with any therapeutic intervention, individualized assessment, clear patient communication, and systematic monitoring remain essential
When alcohol is consumed, the liver prioritizes metabolizing alcohol over maintaining blood glucose, increasing the risk of hypoglycemia, especially in individuals with diabetes
Retatrutide is a novel triple receptor agonist peptide developed by Eli Lilly that simultaneously targets the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR), and glucagon-like peptide-1 receptor (GLP-1R)
First, the nutrient formulations play a significant role
Diabetes Obes Metab 2020;22:631-9